SA Rosenberg

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

EA Grimm, KM Ramsey, A Mazumder et al. · The Journal of Experimental Medicine · 1983 · 469 citations · Full text

Immunology, Immune Regulation, Immunologic Mechanism +16

The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience

RT Hoppe, CN Coleman, R Cox et al. · Blood · 1982 · 289 citations · Full text

Comparison of computed and conventional whole lung tomography in detecting pulmonary nodules: a prospective radiologic-pathologic study

EG Schaner, AE Chang, JL Doppman et al. · American Journal of Roentgenology · 1978 · 231 citations

The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation

RT Hoppe, P Kushlan, Kaplan Hs et al. · Blood · 1981 · 190 citations · Full text

Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients

SE Ettinghausen, JG Moore, DE White et al. · Blood · 1987 · 165 citations · Full text